Songbo Qiu

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion

Bharat K. R. Chaganty, Songbo Qiu, Anneliese M. M. Gest et al. · Cancer Letters · 2018 · 190 citations

Trastuzumab Resistance, Autoimmune Disease, Immunology +13

Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism

Zhihong Ai, Yang Lü, Songbo Qiu et al. · Cancer Letters · 2016 · 182 citations · Full text

Cisplatin Resistance, Oncology, Ovarian Cancer Cells +10

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

Zifei Pei, Liang Chu, Weiguo Zou et al. · Hepatology · 2004 · 151 citations · Full text

Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab

Jingtao Luo, Yun Hong, Yang Lü et al. · Cancer Letters · 2016 · 97 citations · Full text

Oncology, Oncogenic Agent, Medicine +9

ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis

Haiquan Lu, Xinqun Li, Yang Lü et al. · Cancer Letters · 2016 · 64 citations · Full text

Egfr-associated Protein, Oncology, Oncogenic Agent +9